The study's primary goal is to assess the therapy’s tolerability, pharmacokinetics and safety in healthy volunteers.

Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a ...

Love Is Blind alum Kwame Appiah overhauled his diet after an ulcerative colitis diagnosis. "In November [2024], I got just a ...

Omvoh (mirikizumab-mrkz) for moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for ...

Children who were diagnosed with inflammatory bowel disease (IBD) showed a decline in height, weight, and body mass index ...

Love Is Blind alum Kwame Appiah overhauled his diet after an ulcerative colitis diagnosis. “In November [2024], I got just a ...

The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...

Skyrizi had an estimated national TV ad spend of $367.7 million — the highest ad spend of any brand in the top 10.

Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a ...